Business: Biotech redeveloping abandoned drugs for non-small cell lung cancer. uCloudlink - Hong Kong, 2.6 million shares, priced $18-$20.50, ...
News
- Initial public offerings scheduled to debut next week
- Medical research, clinical trials for most diseases take a hit amid pandemic panic
Based on Gentry's work, a small biotech company, Valerion Therapeutics, has recently begun drug-safety studies in macaques. But that work can't be ...
- How to protest during a pandemic and still keep everyone safe from coronavirus: 6 questions ...
... during a pandemic, from the head of infectious diseases at Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo.
- A Lyme disease vaccine doesn't exist, but a yearly antibody shot shows promise at preventing ...
Today, a French biotech company, in collaboration with Pfizer, is attempting to develop a Lyme vaccine that is currently in clinical trials. A different ...
- Council to Weigh $80M Workforce Development Program, Small Business Aid
... Biomed SA, an organization to promote the city's biomedical industry; and the Cybersecurity Council, an advocacy group of the San Antonio ...